GI 360™ Microbiome, Stool

Acinetobacter junii; Actinobacteria; Actinomycetales; Akkermansia muciniphila; Alistipes onderdonkii; Alistipes spp.; Bacilli Class; Bacilli Class; Bacteroides fragilis; Bacteroides pectinophilus; Bacteroides spp.; Bacteroides spp. & Prevotella spp.; Bacteroides stercoris; Bacteroides zoogleoformans; Bifidobacterium spp.; Catenibacterium mitsuokai; Clostridia Class; Clostridium L2-50; Clostridium methylpentosum; Coprobacillus cateniformis; Dialister invisus; Dialister invisus & Megasphaera micronuciformis; Dorea spp.; Enterobacteriaceae; Escherichia spp.; Eubacterium biforme; Eubacterium hallii; Eubacterium rectale; Eubacterium siraeum; Faecalibacterium prausnitzii; Firmicutes; Lachnospiraceae; Lactobacillus ruminis & Pediococcus acidilactici; Lactobacillus spp.; Mycoplasma hominis; Parabacteroides johnsonii; Parabacteroides spp.; Phascolarctobacterium spp.; Proteobacteria; Ruminococcus albus & R. bromii; Ruminococcus gnavus; Streptococcus agalactiae & Eubacterium rectale; Streptococcus salivarius ssp.thermophilus; Streptococcus salivarius ssp.thermophilus & S. sanguinis; Streptococcus spp.; Veillonella spp.; Vibrio cholerae

Stool

This test characterizes the abundance and diversity of more than 45 targeted analytes that peer-reviewed research has shown to contribute to dysbiosis and other chronic disease states. The Dysbiosis Index (DI) is a calculation with scores from 1 to 5 based on the overall bacterial abundance and profile within the patient’s sample as compared to a reference population. Values above 2 indicate a microbiota profile that differs from the defined normobiotic reference population (i.e., dysbiosis). The higher the DI above 2, the more the sample is considered to deviate from normobiosis.